Barry D Quart Heron Therapeutics, Inc. (HRTX) insider trading activity

Barry D Quart is Chief Executive Officer of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 177,989 shares of HRTX, which is worth approximately $275,882. The most recent transaction as insider was on Jan 13, 2023, when has been sold 5,219 shares (Common Stock) at a price of $3.17 per share, resulting in proceeds of $16,544. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 178K

0% 3M change

0% 12M change

Total Value Held $275,882

Barry D Quart Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 13 2023	SELL Payment of exercise price or tax liability	$16,544 $3.17 p/Share	5,219 Reduced 2.85%	177,989 Common Stock
Jan 13 2023	BUY Exercise of conversion of derivative security	-	19,767 Added 9.74%	183,208 Common Stock
Oct 31 2022	BUY Other acquisition or disposition	$5,411 $3.27 p/Share	1,655 Added 1.0%	163,441 Common Stock
Oct 13 2022	SELL Payment of exercise price or tax liability	$19,623 $3.76 p/Share	5,219 Reduced 3.13%	161,786 Common Stock
Oct 13 2022	BUY Exercise of conversion of derivative security	-	19,768 Added 10.58%	167,005 Common Stock
Jul 13 2022	SELL Payment of exercise price or tax liability	$15,709 $3.01 p/Share	5,219 Reduced 3.42%	147,237 Common Stock
Jul 13 2022	BUY Exercise of conversion of derivative security	-	19,768 Added 11.48%	152,456 Common Stock
Apr 29 2022	BUY Other acquisition or disposition	$5,775 $3.84 p/Share	1,504 Added 1.12%	132,688 Common Stock
Apr 13 2022	SELL Payment of exercise price or tax liability	$31,679 $6.07 p/Share	5,219 Reduced 3.83%	131,184 Common Stock
Apr 13 2022	BUY Exercise of conversion of derivative security	-	19,768 Added 12.66%	136,403 Common Stock
Jan 13 2022	SELL Payment of exercise price or tax liability	$43,318 $8.3 p/Share	5,219 Reduced 4.28%	116,635 Common Stock
Jan 13 2022	BUY Exercise of conversion of derivative security	-	19,768 Added 13.96%	121,854 Common Stock
Oct 13 2021	SELL Payment of exercise price or tax liability	$10,160 $10.55 p/Share	963 Reduced 0.93%	102,086 Common Stock
Oct 13 2021	BUY Exercise of conversion of derivative security	-	3,646 Added 3.42%	103,049 Common Stock
Jul 13 2021	SELL Payment of exercise price or tax liability	$12,981 $13.48 p/Share	963 Reduced 0.96%	99,403 Common Stock
Jul 13 2021	BUY Exercise of conversion of derivative security	-	3,645 Added 3.5%	100,366 Common Stock
Apr 30 2021	BUY Other acquisition or disposition	$21,253 $13.9 p/Share	1,529 Added 1.56%	96,721 Common Stock
Apr 13 2021	SELL Payment of exercise price or tax liability	$16,044 $16.66 p/Share	963 Reduced 1.0%	95,192 Common Stock
Apr 13 2021	BUY Exercise of conversion of derivative security	-	3,646 Added 3.65%	96,155 Common Stock
Jan 13 2021	SELL Payment of exercise price or tax liability	$17,488 $18.16 p/Share	963 Reduced 1.04%	91,909 Common Stock
Jan 13 2021	BUY Exercise of conversion of derivative security	-	3,646 Added 3.78%	92,872 Common Stock
Apr 30 2020	BUY Other acquisition or disposition	$14,035 $12.12 p/Share	1,158 Added 1.28%	89,226 Common Stock
Nov 04 2016	BUY Bona fide gift	-	600 Added 0.64%	92,509 Common Stock

Also insider at

KNSA

Kiniksa Pharmaceuticals, Ltd. Healthcare

BDQ

Barry D Quart

Chief Executive Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Heron Therapeutics, Inc. insider buys or sells HRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to HERON THERAPEUTICS, INC.

Track Activities on HRTX

Account